Global Cancer Informatics market is expected to grow at a CAGR of 7.5% during 2021-26

According to the MarkNtel Advisors’ research report, “Global Cancer Informatics Market Analysis, 2021”, the market is expected to grow at a CAGR of 7.5% during 2021-26. The growth of the market is attributed to the rising adoption of cancer-specific electronic health records (EHRs) for monitoring and recording health-related data of patients. In addition to this, the growing number of cancer patients and the high cost associated with the treatment of cancer is fueling the growth of the market. Growing development in the healthcare industry upturns the need for data collection and analysis, thus, the demand for adequate information systems increases. Thereby, contributing lucrative opportunities for the growth of the market.

Key questions answered in the study

1. What are the current and future trends in Global Cancer Informatics market?
2. How the industry has been evolving in terms of geography and services adoption?
3. How the competition has been shaping across the countries followed by their comparative factorial indexing?
4. What are the key growth drivers and challenges for Global Cancer Informatics market?
5. What are the customer orientation, purchase behaviour, and expectations from the Global Cancer Informatics market service provider across various regions?

Pharmaceutical industry Exhibits Fastest Growth

Based on the End-user outlook, the pharmaceutical industry is anticipated to witness the fastest growth during the forecast period. The growth of the segment is due to rising demand to increase the workflow of facilities and enhance the quality of care. In addition to this, the mounting requirement of patient-centric treatment to receive high-quality care is propelling the market growth. Moreover, the increasing trend of personalized medicine could make use of information to come up with an efficient approach to prescribed doses. Thereby, providing growth opportunities to drive the market.

“Global Cancer Informatics Market Analysis, 2021” provides comprehensive qualitative and quantitative insights on the market potential, key factors impacting the market growth, hotspots and opportunities available for Cancer Informatics providers across the globe. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitor's capabilities on 16 parameters. This will help companies in the formulation of Go to Market Strategies and identifying the blue ocean for its offerings. 

Asia-Pacific Exhibits Fastest Growth

The Asia-pacific market is projected to register the fastest growth in the Global Cancer Informatics market during 2021-26. Cancer with the highest level of mutation is highly prevalent in the Asia Pacific region. Further, change in lifestyle, rise in smoking and drinking habits has led to increasing the occurrence of cancer among the people. Thereby, the region is projected to contribute to the growth of the global Cancer Informatics market in the forecast period as revealed by MarkNtel Advisors’ research report “Global Cancer Informatics Market Analysis, 2021”.

According to MarkNtel Advisors, the major leading players in the global Cancer Informatics market are Elekta ab, Varian Medical Systems, Accuray Incorporated, Cerner Corporation, RaySearch Laboratories, Flatiron, Oncology Analytics, Inc, Hologic Inc., F.Hoffmann-La Roche Ltd., McKesson Corporation, etc.

Market Segmentation:

1. By Product (Electronic Health Records (EHRs), Population Health Management (PHM), Clinical Decision Support System (CDSS), Drug Discovery and Development Informatics (DDDI))
2. By Application (Medical Application, Surgical Application, Radiation Application)
3. By Cancer Type (Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Other)
4. By End-Users (Life Science industry, Academic Institutes and Research Centers, Pharmaceutical Companies, Contract Research Organizations (CROs), Others (Hospitals and Other Care Facilities))
5. By Region (North America, South America, Europe, Asia-Pacific, Middle East and Africa)
6. By Country (US, Canada, Mexico, Brazil, UK, Italy, Germany, France, Russia, Spain, Saudi-Arabia, South-Africa, China, India, Japan, South-Korea, Australia)
7. By Competitors (Elekta ab, Varian Medical Systems, Accuray Incorporated, Cerner Corporation, RaySearch Laboratories, Flatiron, Oncology Analytics, Inc, Hologic Inc., F.Hoffmann-La Roche Ltd., McKesson Corporation)